Complex Regional Pain Syndrome Type I
16
2
2
5
Key Insights
Highlights
Success Rate
56% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
25.0%
4 terminated out of 16 trials
55.6%
-31.0% vs benchmark
13%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
The Effects of Whirlpool and Contrast Bath in Patients with Complex Regional Pain Syndrome After Distal Radius Fracture
Longitudinal Follow-up Study About Complex Regional Pain Syndrome (CRPS) Patients
Effect of Kinesiotaping on Pain,Edema and Kinesiophobia in Patients With Complex Regional Pain Syndrome
Mirror Therapy in Complex Regional Pain Syndrome Type I
Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex Regional Pain Syndromes Type 1 of the Upper Limbs
rTMS and Rehabilitation for Individuals With CRPS Type 1
Pain in Complex Regional Pain Syndrome
Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1
Complex Regional Pain Syndrome in Children: Impact of Bergès Relaxation on the Autonomic Balance
Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
Neurotropin to Treat Chronic Neuropathic Pain
Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)